Sipuleucel-T (Provenge).
D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D014020:Tissue Extracts / Q000008:administration & dosage* / Q000009:adverse effects*
D019496:Cancer Vaccines; D014020:Tissue Extracts; C511774:sipuleucel-T